50mg CTx-1301 (Dexmethylphenidate tablet) for Attention Deficit Hyperactivity Disorder (ADHD)
This trial tests if a new medicine is safe and helpful for adults with ADHD in a lab setting.
- Attention Deficit Hyperactivity Disorder (ADHD)
1 Primary · 2 Secondary · Reporting Duration: Baseline (pre-dose) at Visit 8 then post-dose at hours .5,1,3,6,9,12,13,14,15, and 16.
4 Treatment Groups
50mg CTx-1301 (Dexmethylphenidate tablet)
1 of 4
37.5mg CTx-1301 (Dexmethylphenidate tablet)
1 of 4
25mg CTx-1301 (Dexmethylphenidate tablet)
1 of 4
1 of 4
25 Total Participants · 4 Treatment Groups
Primary Treatment: 50mg CTx-1301 (Dexmethylphenidate tablet) · Has Placebo Group · Phase 3
Who is running the clinical trial?
Age 18 - 55 · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does this medical experiment include individuals who are of a more advanced age?
"This research is open to patients that are between 18 and 55 years of age." - Anonymous Online Contributor
Are there any specific criteria for qualifying to participate in this research?
"Prospective participants of this clinical trial must have an ADHD diagnosis and be between 18-55 years old to qualify. Approximately 25 people are being welcomed into the study." - Anonymous Online Contributor
Are there adverse effects associated with the ingestion of 50mg CTx-1301 (Dexmethylphenidate tablet)?
"There is clinical evidence for the safety of 50mg CTx-1301 (Dexmethylphenidate tablet), so it was rated a 3 on our scale. This Phase 3 trial has yielded multiple rounds of data in support of its efficacy and security." - Anonymous Online Contributor
Is enrollment currently open for this research endeavor?
"According to the information hosted on clinicaltrials.gov, recruitment for this experiment is ongoing. It was initially posted on December 29th 2022 and underwent a recent update on January 23rd 2023." - Anonymous Online Contributor
What is the current enrollment capacity of this research endeavor?
"Affirmative. Information featured on clinicaltrials.gov suggests that recruitment is underway for this medical experiment, which was initially advertised on December 29th 2022 and last amended January 23rd 2023. Specifically, 25 individuals must be recruited from 1 particular location." - Anonymous Online Contributor